Hematologic Disease and Disorders / Donors / Healthy Volunteer · Observational Study
ClinicalTrials.gov · August 7, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a screening registry study designed to identify and evaluate subjects eligible for enrollment into active NHLBI research protocols. No clinical outcomes or trial results are reported in this registry record; it is a preliminary operational study intended to funnel participants into future research.
Observational. Hematologic Disease and Disorders, Donors, Healthy Volunteer; age from 2 Years; to 100 Years; accepts healthy volunteers. Intervention: Subjects undergoing screening. n = 10,000. 1 site: United States.
This is a screening registry study designed to identify and evaluate subjects eligible for enrollment into active NHLBI research protocols. No clinical outcomes or trial results are reported in this registry record; it is a preliminary operational study intended to funnel participants into future research.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This is a screening infrastructure study, not a hypothesis-testing trial. Clinicians and researchers should interpret this as a registry record documenting an ongoing recruitment pathway; it does not evaluate the efficacy or safety of any specific intervention.
This is a screening registry study with no reported results; it is observational, hypothesis-generating, and designed to enroll participants into future trials rather than to test an intervention.
As stated by the source record.
Quoted from the source exactly as published.
This is a screening infrastructure study, not a hypothesis-testing trial. Clinicians and researchers should interpret this as a registry record documenting an ongoing recruitment pathway; it does not evaluate the efficacy or safety of any specific intervention.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT00001620). This is a study registration, not published results. Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI). Recruitment status: ENROLLING_BY_INVITATION. Study type: OBSERVATIONAL. Enrollment: 10000 participants (ESTIMATED). Conditions: Hematologic Disease and Disorders, Donors, Healthy Volunteer. Primary outcome measures: Primary endpoint is the results of clinical, imaging and laboratory assessments. , ongoing. Brief summary: This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.